Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis Doc Wire News, 22 Nov 2021 This article was originally published here Neurol Res Pract. 2021 Nov 22;3(1):60.